{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:59:38Z","timestamp":1790135978406,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008793","name":"Manitoba Health Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["NSERC-DG-2018-06047"],"award-info":[{"award-number":["NSERC-DG-2018-06047"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ejmech.2019.05.003","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T12:03:11Z","timestamp":1556798591000},"page":"187-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli"],"prefix":"10.1016","volume":"175","author":[{"given":"Xuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Ammeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1583-8562","authenticated-orcid":false,"given":"Temilolu","family":"Idowu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Domalaon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Brizuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreofe","family":"Okunnu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanelis Acebo","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Zhanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayush","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-5519","authenticated-orcid":false,"given":"Frank","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.05.003_bib1","author":"American Chemical Society International Historic Chemical Landmarks"},{"key":"10.1016\/j.ejmech.2019.05.003_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nrd940","article-title":"The future challenges facing the development of new antimicrobial drugs","volume":"1","author":"Coates","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.05.003_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1465-0691.2004.1007.x","article-title":"Antimicrobial drug development \u2013 the past, the present, and the future","volume":"10","author":"Powers","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2019.05.003_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.05.003_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1517\/17460441.3.5.487","article-title":"Are natural products still the best source for antibacterial discovery? The bacterial entry factor","volume":"3","author":"Silver","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.05.003_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","article-title":"Antibiotic adjuvants: rescuing antibiotics from resistance","volume":"24","author":"Wright","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2019.05.003_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00077-17","article-title":"Antibiotic hybrids: the next generation of agents and adjuvants against gram-negative pathogens?","volume":"31","author":"Domalaon","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2019.05.003_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/anie.201508330","article-title":"Adjuvants based on hybrid antibiotics overcome resistance in Pseudomonas aeruginosa and enhance fluoroquinolone efficacy","volume":"55","author":"Gorityala","year":"2016","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2019.05.003_bib9","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1021\/acs.jmedchem.6b00867","article-title":"Hybrid atibiotic overcomes resistance in P.\u00a0aeruginosa by enhancing outer membrane penetration and reducing efflux","volume":"59","author":"Gorityala","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.003_bib10","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1021\/acs.jmedchem.7b00156","article-title":"A\u00a0tobramycin vector enhances synergy and efficacy of efflux pump inhibitors against multidrug-resistant Gram-negative bacteria","volume":"60","author":"Yang","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.003_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/jcm7070158","article-title":"Tobramycin-linked efflux pump inhibitor conjugates synergize fluoroquinolones, rifampicin and fosfomycin against multidrug-resistant Pseudomonas aeruginosa","volume":"7","author":"Yang","year":"2018","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.ejmech.2019.05.003_bib12","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1021\/acs.jmedchem.6b01742","article-title":"Amphiphilic tobramycin\u2013lysine conjugates sensitize multidrug resistant Gram-negative bacteria to rifampicin and minocycline","volume":"60","author":"Lyu","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.003_bib13","article-title":"Amphiphilic lysine conjugated to tobramycin synergizes legacy antibiotics against wild-type and multidrug-resistant Pseudomonas aeruginosa","author":"Lyu","year":"2017","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejmech.2019.05.003_bib14","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acsinfecdis.7b00145","article-title":"Polymyxin B 3 \u2013tobramycin hybrids with Pseudomonas aeruginosa -selective antibacterial activity and strong potentiation of rifampicin, minocycline, and vancomycin","volume":"3","author":"Domalaon","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.003_bib15","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1128\/AAC.04099-14","article-title":"Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling","volume":"59","author":"Bulitta","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.05.003_bib16","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1016\/S0021-9258(18)93308-9","article-title":"Misreading of ribonucleic acid code words induced by aminoglycoside antibiotics","volume":"243","author":"Davies","year":"1968","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.05.003_bib17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1126\/science.274.5291.1367","article-title":"Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic","volume":"274","author":"Fourmy","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.05.003_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/jmbi.1997.1552","article-title":"Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 s rRNA","volume":"277","author":"Fourmy","year":"1998","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.05.003_bib19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1074-5521(02)00153-9","article-title":"Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding a site","volume":"9","author":"Vicens","year":"2002","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2019.05.003_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0969-2126(02)00934-6","article-title":"Comparison of X-ray crystal structure of the 30S subunit-antibiotic complex with NMR structure of decoding site oligonucleotide-paromomycin complex","volume":"11","author":"Lynch","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2019.05.003_bib21","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/anie.200353225","article-title":"Dimeric aminoglycosides as antibiotics","volume":"43","author":"Agnelli","year":"2004","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2019.05.003_bib22","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1002\/chem.201406404","article-title":"Tobramycin and nebramine as pseudo-oligosaccharide scaffolds for the development of antimicrobial cationic amphiphiles","volume":"21","author":"Berkov-Zrihen","year":"2015","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2019.05.003_bib23","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.1021\/acs.jmedchem.6b00818","article-title":"New broad-spectrum antibacterial amphiphilic aminoglycosides active against resistant bacteria: from neamine derivatives to smaller neosamine analogues","volume":"59","author":"Zimmermann","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.003_bib24","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.bbamem.2011.01.014","article-title":"The Pseudomonas aeruginosa membranes: a target for a new amphiphilic aminoglycoside derivative?","volume":"1808","author":"Ouberai","year":"2011","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejmech.2019.05.003_bib25","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.ejmech.2018.08.022","article-title":"Broad-spectrum antibacterial amphiphilic aminoglycosides: a new focus on the structure of the lipophilic groups extends the series of active dialkyl neamines","volume":"157","author":"Zimmermann","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.003_bib26","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.49.2.849-852.2005","article-title":"Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps","volume":"49","author":"Bohnert","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.05.003_bib27","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1002\/anie.201500598","article-title":"Amphiphilic tobramycins with immunomodulatory properties","volume":"54","author":"Guchhait","year":"2015","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2019.05.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.05.003_bib29","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1128\/AAC.04146-14","article-title":"In\u00a0vitro activity of ceftazidime-avibactam combination in in\u00a0vitro checkerboard assays","volume":"59","author":"Berkhout","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.05.003_bib30","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1128\/AAC.05024-14","article-title":"Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. Medical Centers in 2012 and 2013","volume":"59","author":"Sader","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.05.003_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.idc.2016.02.005","article-title":"Agents of last resort: polymyxin resistance","volume":"30","author":"Kaye","year":"2016","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/j.ejmech.2019.05.003_bib32","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2016"},{"key":"10.1016\/j.ejmech.2019.05.003_bib33","series-title":"Comit\u00e9 de L'Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie-Recommandations 2012","author":"P. Bonnet","year":"2012"},{"key":"10.1016\/j.ejmech.2019.05.003_bib34","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1093\/jac\/dkv111","article-title":"Enhanced efficacy of putative efflux pump inhibitor\/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in\u00a0vivo infection model","volume":"70","author":"Adamson","year":"2015","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.05.003_bib35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1099\/jmm.0.074245-0","article-title":"A\u00a0Galleria mellonella infection model reveals double and triple antibiotic combination therapies with enhanced efficacy versus a multidrug-resistant strain of Pseudomonas aeruginosa","volume":"63","author":"Krezdorn","year":"2014","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.ejmech.2019.05.003_bib36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"Ejim","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2019.05.003_bib37","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bbabio.2011.09.018","article-title":"Chemiosmotic coupling in oxidative and photosynthetic phosphorylation","volume":"1807","author":"Mitchell","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2019.05.003_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1574-6968.1989.tb03412.x","article-title":"Effects of tetracyclines on the production of extracellular proteins by members of the propionibacteriaceae","volume":"60","author":"Chopra","year":"1989","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejmech.2019.05.003_bib39","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1128\/AAC.01538-07","article-title":"Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian national intensive Care unit (CAN-ICU) study, 2005-2006","volume":"52","author":"Zhanel","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2019.05.003_bib40","doi-asserted-by":"crossref","first-page":"i7","DOI":"10.1093\/jac\/dkt022","article-title":"Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study","volume":"68","author":"Zhanel","year":"2013","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.05.003_bib41","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1128\/AAC.00469-10","article-title":"Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008)","volume":"54","author":"Zhanel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.05.003_bib42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/JCM.43.1.140-143.2005","article-title":"Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis","volume":"43","author":"Orhan","year":"2005","journal-title":"J.\u00a0Clin. Microbiol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419304064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419304064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:51:14Z","timestamp":1778676674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419304064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":42,"alternative-id":["S0223523419304064"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.003","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}